RhythmX AI's $50 Million Bet: The Useful Part Comes After the AI Scribe

Most clinical AI is trying to write the note. RhythmX AI wants to decide what deserves the doctor's attention next - and its merger with Get Well reveals why distribution may matter as much as the model.